PFM Health Sciences’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209M | Sell |
268,023
-5,755
| -2% | -$4.49M | 17.79% | 1 |
|
|
2025
Q1 | $226M | Sell |
273,778
-24,865
| -8% | -$20.5M | 16.42% | 1 |
|
|
2024
Q4 | $231M | Hold |
298,643
| – | – | 14.29% | 1 |
|
|
2024
Q3 | $265M | Hold |
298,643
| – | – | 14.99% | 1 |
|
|
2024
Q2 | $270M | Hold |
298,643
| – | – | 13.38% | 1 |
|
|
2024
Q1 | $232M | Hold |
298,643
| – | – | 10.92% | 1 |
|
|
2023
Q4 | $174M | Hold |
298,643
| – | – | 10.44% | 1 |
|
|
2023
Q3 | $160M | Hold |
298,643
| – | – | 7.56% | 1 |
|
|
2023
Q2 | $140M | Hold |
298,643
| – | – | 5.44% | 1 |
|
|
2023
Q1 | $103M | Hold |
298,643
| – | – | 4.53% | 2 |
|
|
2022
Q4 | $109M | Hold |
298,643
| – | – | 3.91% | 3 |
|
|
2022
Q3 | $96.6M | Hold |
298,643
| – | – | 3.49% | 2 |
|
|
2022
Q2 | $96.8M | Hold |
298,643
| – | – | 3.69% | 3 |
|
|
2022
Q1 | $85.5M | Hold |
298,643
| – | – | 3.2% | 7 |
|
|
2021
Q4 | $82.5M | Sell |
298,643
-226,812
| -43% | -$62.6M | 2.81% | 8 |
|
|
2021
Q3 | $121M | Hold |
525,455
| – | – | 3.57% | 3 |
|
|
2021
Q2 | $121M | Hold |
525,455
| – | – | 3.78% | 4 |
|
|
2021
Q1 | $98.2M | Buy |
525,455
+174,810
| +50% | +$32.7M | 3% | 7 |
|
|
2020
Q4 | $59.2M | Buy |
+350,645
| New | +$59.2M | 2.08% | 9 |
|
|
2017
Q2 | – | Sell |
-575,249
| Closed | -$48.4M | – | 96 |
|
|
2017
Q1 | $48.4M | Buy |
+575,249
| New | +$48.4M | 1.21% | 28 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 103 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 89 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 82 |
|
|
2015
Q4 | – | Sell |
-1,106,139
| Closed | -$92.6M | – | 75 |
|
|
2015
Q3 | $92.6M | Buy |
+1,106,139
| New | +$92.6M | 2.6% | 12 |
|